Why Is Trulicity on Backorder? Causes and Solutions Explained
Trulicity, a key medication for type 2 diabetes, has been facing shortages, leaving many patients frustrated. Understanding why is Trulicity on backorder involves looking at demand, production issues, and market trends.
This article breaks down the reasons behind the shortage in simple terms. It also offers practical steps to manage the situation while keeping your diabetes under control.
What Is Trulicity and Its Importance?
Trulicity, or dulaglutide, is a weekly injectable drug for adults and children over 10 with type 2 diabetes. It’s a GLP-1 receptor agonist that helps lower blood sugar and reduces heart disease risk. Many rely on it to maintain stable glucose levels and improve overall health. Its popularity stems from its effectiveness and once-weekly dosing.
The drug is manufactured by Eli Lilly, a major pharmaceutical company. Trulicity’s role in diabetes management makes its availability critical. When it’s on backorder, patients face challenges in maintaining consistent treatment. This can lead to health complications if not addressed promptly.
Reasons Behind the Trulicity Shortage
Surge in Demand for GLP-1 Medications
The demand for GLP-1 drugs like Trulicity has skyrocketed recently. This is partly due to their weight loss benefits, even though Trulicity is not FDA-approved for this purpose. Social media and celebrity endorsements have fueled off-label use, straining supplies. The increased demand has outpaced Eli Lilly’s production capacity.
Impact of Ozempic Shortages
The shortage of Ozempic, another GLP-1 drug, has directly affected Trulicity’s availability. When Ozempic became scarce, many patients switched to Trulicity, overwhelming its supply chain. This ripple effect began around June 2022 and continues to impact Trulicity stocks. The interconnected demand for diabetes medications has created a bottleneck.
Production and Supply Chain Challenges
Global supply chain disruptions have hit pharmaceutical manufacturing hard. Issues like raw material shortages, shipping delays, and COVID-19-related setbacks have slowed Trulicity production. Eli Lilly has struggled to keep up with demand while facing these logistical hurdles. These challenges contribute to why is Trulicity on backorder.
Shift in Manufacturing Priorities
Eli Lilly has shifted focus to newer GLP-1 drugs like Mounjaro and Zepbound. These medications are in high demand, and the company is allocating resources to boost their production. This shift has reduced Trulicity’s manufacturing capacity, especially for higher doses (3.0 mg and 4.5 mg). The reallocation of resources has worsened the shortage.
How the Shortage Affects Patients
Missing Trulicity doses can disrupt blood sugar control. Within a week or two, patients may notice higher glucose levels, fatigue, or blurry vision. Weight regain is also possible if Trulicity was aiding weight loss. These effects can be stressful and harmful if prolonged.
Patients like Robbie McLean from Tennessee have shared their struggles. Unable to refill prescriptions, they face uncertainty about when supplies will return. Pharmacies often can’t predict restocking dates, adding to the frustration. The shortage disrupts treatment plans and daily life.
Which Doses Are Most Affected?
The FDA reports that Trulicity’s 3.0 mg and 4.5 mg doses are in limited supply. These higher doses are often used as maintenance doses for better blood sugar control. Lower doses (0.75 mg and 1.5 mg) are generally more available. However, availability varies by pharmacy and region.
| Trulicity Dose | Availability Status | Notes |
|---|---|---|
| 0.75 mg | Generally available | Often used as starting dose. |
| 1.5 mg | Mostly available | Common maintenance dose. |
| 3.0 mg | Limited supply | Shortage expected until mid-2026. |
| 4.5 mg | Limited supply | Highest dose, hardest to find. |
This table shows the current status of Trulicity doses based on FDA and Eli Lilly updates.
Steps to Navigate the Trulicity Shortage
Contact Your Pharmacist
Start by checking with your pharmacy for Trulicity availability. Ask if they have a backorder list to notify you when stock arrives. Some pharmacies can check other locations for supply. Calling around to different pharmacies may help you find available doses.
Explore Lower Doses
If higher doses are unavailable, ask your doctor about using lower doses like 1.5 mg. Studies show lower doses are slightly less effective but still beneficial. Your doctor can adjust your treatment plan to maintain control. This can be a temporary solution until supplies stabilize.
Consider Alternative Medications
Several GLP-1 drugs can replace Trulicity if needed. Here are some alternatives:
- Ozempic (semaglutide): Similar to Trulicity, but also in short supply.
- Victoza (liraglutide): Daily injection with comparable effects.
- Bydureon (exenatide): Another weekly injection option.
Discuss these with your doctor to find the best fit. Check insurance coverage, as alternatives may vary in cost.
Use Online Pharmacies and Assistance Programs
Online pharmacies or patient assistance programs may offer Trulicity or alternatives at lower costs. Eli Lilly provides support programs for eligible patients. These options can help bridge the gap during shortages. Always verify the legitimacy of online sources to avoid counterfeit drugs.
Monitor Your Health Closely
Track your blood sugar levels regularly during the shortage. Use a glucometer to spot changes early. Report symptoms like fatigue or high glucose to your doctor. Staying proactive helps prevent complications while you wait for Trulicity.
What Eli Lilly Is Doing About It
Eli Lilly is investing in new manufacturing facilities to boost Trulicity production. A $450 million plant in North Carolina aims to double capacity by late 2025. The company is also working with wholesalers to distribute stock fairly. However, full resolution may take until mid-2026.
Eli Lilly has warned against counterfeit Trulicity from unverified sources. They encourage reporting fake products to their support line (1-800-545-5979). The company is also collaborating with the FDA to manage the shortage. These efforts aim to restore reliable supply soon.
Global Impact of the Shortage
The Trulicity shortage isn’t limited to the United States. Countries like Australia, Austria, and Sweden face similar issues. In Australia, the Therapeutic Goods Administration (TGA) reports shortages until June 2026. The global demand for GLP-1 drugs has strained supplies worldwide.
In Europe, the European Medicines Agency (EMA) is monitoring the situation. They’re working with Eli Lilly to mitigate impacts. Patients in affected countries are advised to consult healthcare providers for alternatives. The global nature of the shortage highlights the widespread reliance on Trulicity.
Avoiding Common Pitfalls During the Shortage
Don’t Stockpile Medication
Hoarding Trulicity can worsen the shortage for others. Stick to your prescribed amount and refill only as needed. Pharmacies are managing limited stock, so over-ordering creates delays. Work with your pharmacist to plan refills wisely.
Avoid Unverified Sources
Counterfeit Trulicity poses serious health risks. Only purchase from licensed pharmacies or Eli Lilly’s approved channels. Unapproved products may lack safety or efficacy. Report suspicious sources to Eli Lilly or the FDA immediately.
Don’t Skip Doses Without Guidance
Missing doses can spike blood sugar and cause complications. If Trulicity is unavailable, consult your doctor before stopping. They can prescribe alternatives or adjust your plan. Never make changes on your own.
Lifestyle Tips to Support Diabetes Management
A healthy diet can help stabilize blood sugar during the shortage. Focus on low-carb foods like vegetables, lean proteins, and whole grains. Avoid sugary snacks to prevent glucose spikes. Small, frequent meals can keep levels steady.
Regular exercise, like walking or yoga, supports blood sugar control. Aim for 30 minutes most days, but check with your doctor first. Staying active complements medication and reduces reliance on Trulicity. Hydration also helps manage symptoms and overall health.
Summary
The Trulicity shortage stems from high demand, Ozempic-related ripple effects, supply chain issues, and Eli Lilly’s focus on newer drugs. Higher doses (3.0 mg and 4.5 mg) are most affected, with shortages expected until mid-2026.
Patients can manage by checking pharmacies, using lower doses, or switching to alternatives like Ozempic or Victoza. Eli Lilly is expanding production, but challenges remain. Monitor your health, avoid counterfeit drugs, and work with your doctor to stay on track.
FAQ
Why is Trulicity on backorder right now?
High demand for GLP-1 drugs, Ozempic shortages, and supply chain disruptions are the main causes. Eli Lilly’s focus on newer drugs like Mounjaro also limits Trulicity production. Shortages may persist until mid-2026.
Which Trulicity doses are hardest to find?
The 3.0 mg and 4.5 mg doses are in limited supply. Lower doses (0.75 mg and 1.5 mg) are generally more available. Check with pharmacies for local stock updates.
What can I do if I can’t get Trulicity?
Call pharmacies to check availability or join a backorder list. Ask your doctor about lower doses or alternatives like Ozempic or Victoza. Monitor blood sugar closely to avoid complications.
Are there risks to using alternative medications?
Alternatives like Victoza or Bydureon are generally safe but may have different side effects. Your doctor will choose one based on your health needs. Always follow their guidance for safe switching.
How is Eli Lilly addressing the shortage?
Eli Lilly is investing $450 million in a new manufacturing plant to boost capacity. They’re working with wholesalers to distribute stock fairly. Full resolution is expected by mid-2026.